These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9247663)

  • 1. Screening for prostatic carcinoma: case finding is not the problem.
    France MW; Seneviratne CJ
    Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():333-8. PubMed ID: 9247663
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer and PSA screening.
    Mameghan H
    Aust Fam Physician; 1999 Aug; 28(8):777-81. PubMed ID: 10495525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of prostate-specific antigen in prostate cancer.
    Liang SL
    MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of current diagnostic tests in prostate cancer screening.
    Van Der Cruijsen-Koeter IW; Wildhagen MF; De Koning HJ; Schröder FH
    BJU Int; 2001 Sep; 88(5):458-66. PubMed ID: 11589658
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostatic cancer screening].
    Brasso K; Iversen P
    Ugeskr Laeger; 2002 Jan; 164(2):155-7. PubMed ID: 11831076
    [No Abstract]   [Full Text] [Related]  

  • 6. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for prostate cancer: the case for.
    Malone P
    Ann R Coll Surg Engl; 2005 Mar; 87(2):88-9; discussion 88. PubMed ID: 15826414
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 10. AUA issues a policy report on PSA monitoring. The American Urological Association.
    Scott Morey S
    Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer screening: the need for problem-solving that puts men's interests first.
    Holmberg L
    Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective.
    Hayes JH; Barry MJ; Kantoff PW; Stahl JE
    BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139
    [No Abstract]   [Full Text] [Related]  

  • 13. PSA screening.
    Cohen S; Schiff S; Kelty P
    Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
    [No Abstract]   [Full Text] [Related]  

  • 14. Should Canadians be offered systematic prostate cancer screening? No.
    Labrecque M; Légaré F; Cauchon M
    Can Fam Physician; 2007 Jun; 53(6):989-92, 994-7. PubMed ID: 17872765
    [No Abstract]   [Full Text] [Related]  

  • 15. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 17. New Zealand should introduce population screening for prostate cancer using PSA testing: yes.
    Smart R
    J Prim Health Care; 2009 Dec; 1(4):319-20. PubMed ID: 20690342
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer screening.
    Stattin P; Stenman UH; Riboli E; Hallmans G; Kaaks R
    Lancet; 2001 Apr; 357(9263):1202-3. PubMed ID: 11332426
    [No Abstract]   [Full Text] [Related]  

  • 19. Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.
    Höltl W; Lunglmayr G
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):440-1. PubMed ID: 16091868
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliability of PSA testing remains unclear.
    Ciatto S
    BMJ; 2003 Sep; 327(7417):750. PubMed ID: 14512493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.